CHICAGO, July 1, 2024
/PRNewswire/ -- Anbio Biotechnology ("Anbio"), a leading global
diagnostic solution provider, is excited to announce its
participation in the ADLM 2024 Clinical Lab Expo (formerly the AACC
Clinical Lab Expo). The event will take place from July 30th to August 1st at McCormick Place in
Chicago, Illinois, USA. Following
a successful turnout last year in Anaheim, California, Anbio is set to return to
ADLM, ready to showcase its evolved point-of-care testing (POCT)
product portfolios to the public.
Anbio is proud to offer diagnostic technologies renowned for
their first-in-class accuracy, sensitivity, quality, and
robustness. At this year's expo, we will showcase our innovative
range of laboratory and point-of-care solutions, including the
Immunofluorescence AF Series, Chemiluminescence Immunoassay ADL
Series, Dry Chemistry SHA Series, LFIA solution, and Molecular Dx
solution. Our extensive portfolio features hundreds of IVD products
covering areas such as inflammation, diabetes, cancer markers,
hormones, enzymes, infectious diseases, and drugs of abuse tests.
We invite you to visit Anbio at Booth #3818 to discover our
cutting-edge solutions.
"We are honored to attend ADLM 2024 and showcase our IVD
products," said Michael Lau, CEO of
Anbio Biotechnology. "We are dedicated to collaborating with our
partners to make Anbio's diagnostic solutions accessible to
everyone in need."
About Anbio Biotechnology
Anbio Biotechnology is devoted to make contributions for human
health and has never stopped our goal to innovate in life sciences.
Driven by continuous technical development and integration,
resulting from close cooperation with prestigious institutes across
the world. Anbio always strives to provide total solutions in
clinical diagnosis field, by offering extensive diagnostic products
including laboratory and point-of-care products.
For more information, please
visit: https://www.anbio.com/
View original content to download
multimedia:https://www.prnewswire.com/news-releases/anbio-biotechnology-to-showcase-at-adlm-2024-with-evolved-in-vitro-diagnostic-solutions-302185961.html
SOURCE Anbio Biotechnology